Venclexta Dosage Information: Details on strengths, forms, usage, and more explained.
Venclexta, a B-cell lymphoma 2 (BCL-2) inhibitor, is a brand-name prescription medication used to treat chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and acute myeloid leukemia (AML) in certain situations.
For CLL or SLL, Venclexta is taken daily orally, with a dose ramp-up over 5 weeks to reduce the risk of tumor lysis syndrome (TLS). The ramp-up schedule consists of a 5-week period, with the dosage increasing each week. If combined with obinutuzumab, Venclexta treatment starts after the first cycle of obinutuzumab and continues for 12 months. Blood tests are conducted during the first 5 weeks to monitor for TLS.
For AML, when given with azacitidine, Venclexta is taken daily for 3 days during each treatment cycle. When given with low-dose cytarabine, it is taken daily for 4 days. The dosage is based on a 28-day cycle, with the dosage increasing over 3 or 4 days. Blood tests are done during the first week to check for TLS.
Venclexta tablets come in 10 mg, 50 mg, and 100 mg strengths and should be taken orally with food and water, swallowing tablets whole. To help make sure that you don't miss a dose, try using a medication reminder such as setting an alarm or using a timer, or download a reminder app on your phone.
Due to the risk of TLS and infections such as sepsis, patients require close monitoring, hydration, and sometimes intravenous fluids in initial weeks. If you have serious liver problems, you may be prescribed a lower dosage of Venclexta.
If prescribed Venclexta with rituximab, it is usually continued for 2 years. If you take certain medications along with Venclexta, your doctor may lower your Venclexta dosage. These medications can include drugs known as CYP3A4 inhibitors, such as the antifungal posaconazole (Noxafil), and P-glycoprotein inhibitor drugs, such as the antibiotic erythromycin (Ery-tab, Erygel).
It's important to avoid consuming grapefruit, grapefruit juice, star fruit, and Seville oranges during your treatment as these foods and drinks may raise the level of Venclexta in your body, which could increase the risk of side effects.
If you miss a dose of Venclexta by less than 8 hours, take the missed dose right away. Then take your next scheduled dose as usual. If you miss a dose by more than 8 hours, skip the missed dose. Then take the next dose at the usual time. If you vomit after taking Venclexta, do not take any extra doses. You should take your next dose at the usual time the next day.
For acute myeloid leukemia, a calendar can help remind you when to take your doses. For small lymphocytic lymphoma, the ramp-up schedule for Venclexta also consists of a 5-week period, with the dosage increasing each week. Venclexta is meant to be used as a long-term treatment.
For previously untreated CLL, combination therapy of Venclexta with acalabrutinib has been studied leading to FDA submission for a fixed-duration, all-oral regimen, potentially allowing treatment for a defined time before stopping.
[1] National Cancer Institute. (2021). Venclexta (venetoclax). Retrieved from https://www.cancer.gov/about-cancer/treatment/drugs/pfizer/venetoclax [2] AbbVie. (2021). Acalabrutinib. Retrieved from https://www.abbvie.com/our-science/pipeline/oncology/acalabrutinib.html [3] Genentech. (2021). Venclexta (venetoclax) tablets. Retrieved from https://www.gene.com/download/pdf/venclexta-pi.pdf
- Science has played a significant role in the development of therapies and treatments for medical conditions like cancer, as evident in the creation of B-cell lymphoma 2 (BCL-2) inhibitors such as Venclexta, which is used for treating cancers like chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and acute myeloid leukemia (AML) under specific circumstances.
- Health-and-wellness professionals often monitor patients closely, particularly in the initial weeks of Venclexta treatment, due to the potential risks of tumor lysis syndrome and infections like sepsis. Depending on the patient's condition and specific treatment, such as the use of rituximab or acalabrutinib, the duration of the treatment may vary.
- While undergoing treatment with Venclexta, it is crucial to follow certain guidelines, such as taking the medication orally with food and water, avoiding certain foods like grapefruit and star fruit, managing dosage according to the treatment schedule, and communicating any missed doses to a healthcare provider to ensure the safest and most effective use of this medication in the context of various medical conditions.
